Doxorubicin in disseminated osteosarcoma.

Suppr

超能文献

作者信息

Cores E P, Holland J F, Wang J J, Sinks L F

出版信息

JAMA. 1972 Sep 4;221(10):1132-8. doi: 10.1001/jama.221.10.1132.

DOI:10.1001/jama.221.10.1132

PMID:4512088

Abstract

摘要

相似文献

Doxorubicin in disseminated osteosarcoma.

JAMA. 1972 Sep 4;221(10):1132-8. doi: 10.1001/jama.221.10.1132.

Results of a clinical trial with intermittent doses of adriamycin in lung cancer.

Eur J Cancer (1965). 1972 Oct;8(5):485-9. doi: 10.1016/0014-2964(72)90098-9.

Amputation and adriamycin in primary osteosarcoma.原发性骨肉瘤的截肢术与阿霉素治疗

N Engl J Med. 1974 Nov 7;291(19):998-1000. doi: 10.1056/NEJM197411072911903.

Adjuvant therapy of operable primary osteosarcoma-cancer and Leukemia Group B experience.可手术原发性骨肉瘤的辅助治疗——癌症与白血病B组的经验

Recent Results Cancer Res. 1978;68:16-24. doi: 10.1007/978-3-642-81332-0_3.

[Adriamycin in chemotherapy of solid tumors].[阿霉素在实体瘤化疗中的应用]

Minerva Med. 1975 May 9;66(35):1653-63.

Chemoresponsiveness of Moloney sarcoma virus-induced osteosarcoma to adriamycin in the rat.莫洛尼肉瘤病毒诱导的大鼠骨肉瘤对阿霉素的化疗反应性

Cancer Res. 1978 Jun;38(6):1561-7.

Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study.持续静脉输注异环磷酰胺与多柔比星联合方案作为中国复发性或难治性骨肉瘤患者的二线化疗：一项回顾性研究

Asian Pac J Cancer Prev. 2015;16(6):2391-5. doi: 10.7314/apjcp.2015.16.6.2391.

[Aggressive cytostatic treatment of osteogenic sarcoma in childhood (author's transl)].

Dtsch Med Wochenschr. 1981 Feb 13;106(7):200-7. doi: 10.1055/s-2008-1070287.

Osteosarcoma--the winds of change.骨肉瘤——变革之风。

S Afr Med J. 1978 May 6;53(18):695-8.

Adriamycin in the adjuvant treatment of operable osteosarcoma.阿霉素在可手术骨肉瘤辅助治疗中的应用。

Recent Results Cancer Res. 1978;68:25-7. doi: 10.1007/978-3-642-81332-0_4.

引用本文的文献

BOGO: A Proteome-Wide Gene Overexpression Platform for Discovering Rational Cancer Combination Therapies.BOGO：一个用于发现合理癌症联合疗法的全蛋白质组基因过表达平台。

bioRxiv. 2025 Sep 7:2025.09.02.673780. doi: 10.1101/2025.09.02.673780.

Targeting metastasis in paediatric bone sarcomas.靶向治疗小儿骨肉瘤的转移

Mol Cancer. 2025 May 29;24(1):153. doi: 10.1186/s12943-025-02365-z.

Post-treatment late and long-term effects in bone sarcoma: A scoping review.骨肉瘤治疗后的晚期和长期影响：一项范围综述。

J Bone Oncol. 2025 Mar 21;52:100671. doi: 10.1016/j.jbo.2025.100671. eCollection 2025 Jun.

β-Escin inhibits the proliferation of osteosarcoma cells blocking the PI3K/Akt pathway.β-七叶皂苷通过阻断PI3K/Akt信号通路抑制骨肉瘤细胞的增殖。

RSC Adv. 2018 Aug 21;8(52):29637-29644. doi: 10.1039/c8ra03578d. eCollection 2018 Aug 20.

In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.原位递送阿霉素和顺铂的可注射温敏水凝胶用于增强骨肉瘤治疗。

Int J Nanomedicine. 2022 Mar 22;17:1309-1322. doi: 10.2147/IJN.S356453. eCollection 2022.

Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.靶向骨肉瘤治疗效果和耐药性的分子机制：当前和未来策略的综述。

Int J Mol Sci. 2020 Sep 19;21(18):6885. doi: 10.3390/ijms21186885.

Development and validation of a nomogram for osteosarcoma-specific survival: A population-based study.骨肉瘤特异性生存列线图的开发与验证：一项基于人群的研究。

Medicine (Baltimore). 2019 Jun;98(23):e15988. doi: 10.1097/MD.0000000000015988.

Doxorubicin Redox Biology: Redox Cycling, Topoisomerase Inhibition, and Oxidative Stress.阿霉素的氧化还原生物学：氧化还原循环、拓扑异构酶抑制与氧化应激

React Oxyg Species (Apex). 2016;1(3):189-198. doi: 10.20455/ros.2016.835.

Expression and significance of secreted protein acidic and rich in cysteine in human osteosarcoma.分泌性富含半胱氨酸的酸性蛋白在人骨肉瘤中的表达及意义

Oncol Lett. 2017 Nov;14(5):5491-5496. doi: 10.3892/ol.2017.6871. Epub 2017 Sep 1.

Uev1A facilitates osteosarcoma differentiation by promoting Smurf1-mediated Smad1 ubiquitination and degradation.Uev1A通过促进Smurf1介导的Smad1泛素化和降解来促进骨肉瘤分化。

Cell Death Dis. 2017 Aug 3;8(8):e2974. doi: 10.1038/cddis.2017.366.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验